The CLIC Virtual Tour is designed to give everyone involved with the CTSA Program, regardless of in what capacity, an overview of what CLIC provides and how to make it work for you. Think: a virtual ‘walk-through’ of new website resources, ways to communicate and guidance on how to access. It will be a multipart series, including live question and answer sessions. Videos will be released on the
- -NCATSJoin NCATS SBIR/STTR and CTSA awardee company Melax Tech for a panel discussion hosted by Lili Portilla, M.P.A. Learn how Melax Tech successfully leveraged the SBIR grant in the development of their natural language processing technology with additional support from the CTSA program.
- By: Michael G. Kurilla, M.D., Ph.D., NCATS Director of the Division of Clinical Innovation COVID continues to prove itself remarkably tenacious and provided a Thanksgiving surprise with a new variant of concern, omicron. For those keeping track, we’re now about two-thirds of the way through the Greek alphabet. If we run out of Greek letters, WHO has considered using constellations which means the
- By: Michael G. Kurilla, M.D., Ph.D., NCATS Director of the Division of Clinical Innovation The last 21 months have witnessed the most significant upheaval in our lives, both professional as well as personal due to COVID (and we’re still not out of the woods yet). During this time, NCATS has managed to issue the next generation suite of FOAs for the CTSA program as well as hold two technical
By: Audie Atienza, Ph.D., NCATS Program Officer; Sanae ElShourbagy Ferreira, Ph.D., NCATS Health Specialist; and Michael G. Kurilla, M.D., Ph.D., NCATS Director of the Division of Clinical Innovation While SARS-CoV-2 has demonstrated remarkable tenacity in terms of successfully navigating pharmaceutical as well as non-pharmaceutical interventions with waves of new variants throughout this pandemic
- September 16, 2021
In March of 2020, the pandemic drove Coloradans to enter lockdown mode. This was no different for researchers on the CU Anschutz Medical Campus. The result was that research operations were completely shuttered unless they were related to COVID-19 or essential to patient care. A group of researchers from across the country wanted to learn how different institutions handled closing research down
- September 14, 2021
The grant, awarded by the National Institutes of Health, is one of the largest ever to the medical school. It will support the work of the Irving Institute for Clinical and Translational Research, led by Muredach Reilly, MBBCh, MSCE, professor of medicine and associate dean for clinical and translational research. The Institute works in partnership with researchers and clinicians across Columbia
First a bit on COVID, then a small request. COVID will surely provide a wealth of material for future Monday morning armchair quarterbacking. One aspect (among many) of the overall public health response that has received harsh and severe criticism has been the approach, style, and substance of communications with the general public. From the WHO’s early tagline of ‘we have no evidence’ to the
A publication in Science Translational Medicine from last month, ‘Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States’ is noteworthy for several highlights. Beyond the science of the article itself, the fact that this work represents the efforts of two CTSAs (University of Alabama at Birmingham Center for Clinical and Translational Science
- August 11, 2021NCATS recently solicited feedback on the NCATS CTSA Program from the stakeholder community through a variety of mechanisms, including through a 2019 public Request for Information (NOT-TR-19-027) and general feedback from CTSA application peer reviewers (video). The most recent comments and questions were received in response to the presentation and discussion of the CTSA Program Funding
- -Washington UniversityKL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Cicely W. Fadel, MD, PhD from Harvard Medical School, hosted by Washington University in St. Louis will present her research on Gut Interrupted: Modeling Microbiome-Dependent Modulation of Premature Infant Intestinal Vulnerability
- By: Dr. Sanae ElShourbagy Ferreira, NCATS Health Specialist and Dr. Michael G. Kurilla, NCATS Director of the Division of Clinical Innovation Although COVID-19 infections are decreasing and vaccinations among the adult population hover around 50%, COVID-19 is not quite yet in our rear-view mirror due to a combination of uncertainty regarding durability of immunity conferred by either vaccination
- -Meeting Theme: Intentional Disruption and Innovation: The Future of Translational Science Objective: To highlight changes and innovations that CTSA Program consortium hubs had to make during the COVID pandemic; describing the creative innovations developed and what they suggest concerning intentionally causing the disruption and spurring innovative solutions in the post-COVID world.
- The ‘Un-Meeting’ format which begins with a topic and little in the way of an agenda offers a unique opportunity to explore areas where multiple types of stakeholders with multiple perspectives can interact to focus attention on an issue for which there is no clear ownership or leadership. In this manner, areas that struggle to define themselves begin to come into focus. Recently, the CTSA
- Guest Blog by Dr. Joni L. Rutter, NCATS Acting Director Greetings! It is my pleasure to be a guest on Mike’s Blog this month. While I have not yet met some of you, I hope this can serve as an introduction in my new capacity as Acting Director of the National Center for Advancing Translational Sciences. It has just been a few weeks since Dr. Austin’s departure, and you may be wondering how this
- University Of Southern California
Manuscript appearing in the Journal of Clinical and Translational Science, published online April 20, 2021.
- -University Of California San Diego
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Sarah E. Lutz, PhD from the University of Chicago, hosted by the University of California San Diego will present her research on Blood-Brain Barrier Caveolin-1 Promotes Leukocyte Vascular Extravasation in CNS Autoimmunity.
- Guest Blog by Dr. Audie Atienza, NCATS Program Officer and Dr. Sanae ElShourbagy Ferreira, NCATS Health Specialist On March 26, 2021, The CTSA Program held an “Un-meeting”, organized by CLIC and CTSC of Cleveland, on the topic of “Tackling the Digital Divide to Improve Telehealth”. This un-meeting brought together 104 participants, representing 32 CTSA hubs, to inform the consortium and those
- -Wake Forest University Health Sciences
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Kirsten M. Wright, ND, MCR, MS from Oregon Health and Science University hosted by Wake Forest School of Medicine will present her research on "Using a Home-Based Monitoring Platform to Explore Real-World Routines and Nutrition Behavior in Older Adults at Risk
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Mathew Cherian MD, from Ohio State University, hosted by the National Center for Advancing Translational Sciences will present his research on "Tolerable Strategies to Overcome Treatment Resistance in Breast Cancer" Resistance to first-line endocrine and cyclin
- -University Of Pittsburgh At Pittsburgh
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar program. Alex Bokov, PhD from the University of Texas Health Science Center San Antonio is hosted by the University of Pittsburgh, will discuss his research on "Mining EHR Data for Improved Outcomes Prediction".
- -University Of California San Diego
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Marina Walther-Antonio, PhD from the Mayo Clinic Rochester, hosted by the University of California San Diego will present her research on "The Microbiome Side of Endometrial Cancer.
Public health now has a 3rd arrow in its quiver in the form of another COVID vaccine. The J&J vaccine is the first to offer a single dose with refrigeration requirements suitable for a wider array of health care settings. All that said, vaccine hesitancy remains an obstacle to an effective public health response. In this regard, CTSAs are playing a critical role in addressing public concerns about
- March 05, 2021Melissa A. Haendel, PhD, has been named Chief Research Informatics Officer (CRIO) for the University of Colorado Anschutz Medical Campus, a newly created position responsible for transforming the campus use of information and information systems to accelerate biomedical discoveries, streamline health system operations, and continuously improve patient care. The CRIO office will lead efforts to
- -University Of Washington
The CTSA Center for Leading Innovation and Collaboration (CLIC) program has created the new NIH Clinical and Translational Science Award (CTSA) Visiting Scholars Program to help promote networking among KL2 Scholars. During the pandemic, KL2 Scholars are unable to visit other institutions or conferences to give presentations and network as they have in the past. This new program provides scholars
- -University Of Pennsylvania
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Melissa Barker-Haliski, PhD from the University of Washington, hosted by the University of Pennsylvania will present her research on the "Impact of Chronic Seizures on Cognitive and Neuropsychiatric Comorbidities in AD-Associated Preclinical Models."
- -Harvard Medical School
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Heather Watchel, MD from the University of Pennsylvania, hosted by the Harvard Medical School will present her research on “Circulating microRNA Signatures in Primary Hyperparathyroidism.”
- -Medical University Of South Carolina
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Aaron Seaman, PhD from the University of Iowa, hosted by the Medical University of South Carolina will present his research on "Identifying the Care Delivery Needs and Outcomes for Rural Head and Neck Cancer Survivorship." Survivors of head and neck cancer (HNC
The CTSA Program strives to deliver scientific and system changes that solve the many outstanding problems limiting the efficiency, effectiveness, and reach of clinical translational research, and thus get more treatments to more patients more quickly across the country. As the largest clinical translational science network and as an exemplar to team science, NCATS envisions the CTSA Program
- -University Of Miami School Of MedicineKL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Chandylen Nightingale, PhD, MPH from the Wake Forest School of Medicine, hosted by the University of Miami School of Medicine will present her research on “Examining Capacity in Community Oncology and Moving the Needle to Improve Supportive Care Delivery for